[FATE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
03-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -6.08%
YoY- -86.42%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 933 58,980 44,356 14,981 18,549 18,414 17,067 -85.67%
PBT -52,755 -18,881 -56,363 -83,563 -76,105 -65,690 -68,621 -16.11%
Tax -4,381 -9,711 -8,056 -2,828 -757 -8,777 -2,206 58.19%
NP -52,755 -9,170 -48,307 -80,735 -76,105 -56,913 -68,621 -16.11%
Tax Rate - - - - - - - -
Total Cost 53,688 68,150 92,663 95,716 94,654 75,327 85,688 -26.84%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -5,654.34 -15.55 -108.91 -538.92 -410.29 -309.07 -402.07 485.44%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.54 -0.09 -0.50 -0.83 -0.79 -0.59 -0.72 -17.49%
EPS Diluted -0.54 -0.09 -0.50 -0.83 -0.79 -0.59 -0.72 -17.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.